🎯 3 free searches remaining

Back to Search
TSX

TerrAscend Corp.

TSND.TOHealthcareDrug Manufacturers - Specialty & Generic
Current Price
$0.96
Today's Change
+3.23%
Market Cap
$287.89M
Volume
118.57K

💡 Quick Take

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the U.S. Key strengths include a solid gross margin of 52.8% and an EBITDA margin of 26.4%, indicating effective cost management. However, concerns arise from a negative net margin of -12.2% and a high debt-to-equity ratio of 2.54, suggesting potential financial strain. The current ratio of 1.51 indicates adequate liquidity, but the quick ratio below 1 raises caution about short-term obligations. Overall, while the company shows strong operational efficiency, its profitability and leverage warrant attention.

Based on 28 data points⚠️Not financial advice

📊 Key Metrics

52 Week High$2.00
52 Week Low$0.30
Avg Volume298.88K
Beta2.04
Shares Outstanding309.56M

🔥 Valuation

Market Cap$287.89M
Enterprise Value$528.78M
P/E Ratio-6.64
EV/EBITDAN/A
Dividend Yield0.00%

Loading financial metrics...

🚩 Red Flags

🟠

Significant Losses

Company posted a loss of $-79.5M over the last year, representing 30.4% of revenue.

🟠

High Debt Load

Debt of $223.1M is 5.7x the company's cash position of $39.4M.

🟡

Revenue Softening

Revenue decreased 11.9% year-over-year from $297.0M to $261.7M.

🌟 Opportunities

🚀

Operating margin expanded by 22.0pp, demonstrating strong operational leverage.

🚀

Both gross margin (+2.2pp) and operating margin (+22.0pp) are expanding simultaneously, indicating the company is scaling profitably.

💪

Strong gross margin of 52.0% reflects healthy unit economics.

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free users:3 reports remaining

Recent Developments

Loading news...